The intravenous route was the most common route of immunoglobulin administration (n = 32), followed by the conventional subcutaneous (n = 16) and facilitated subcutaneous (n = 10) routes.

New York, June 18, 2020 -- Reportlinker.com announces the release of the report "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" -.

The subcutaneous route may be unreliable in patient with conditions that result in impaired blood flow, such as circulatory shock (Dougherty and Lister, 2015). It is often suggested that the ...

Subcutaneous routes essentially require placing the needle beneath the skin in certain locations; it’s easier to do. So, I think it presents an opportunity to allow for care in the home ...

Immune-related reactions occurred five-times less frequently in the subcutaneous arm compared with the intravenous arm (13% vs. 66%); 81% of patients received prophylactic anticoagulants, with ...

No dilution is required for the subcutaneous route of administration. The Food and Drug Administration (FDA) has approved Boruzu ™, a ready-to-use formulation of bortezomib for subcutaneous ...

Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and ...

Subcutaneous insulin infusion (CSII) is the gold standard for type 1 diabetic patient therapy. Less physiological than intraperitoneal administration, the subcutaneous route may induce glycemic ...

A detailed assessment of the current market landscape of commercially available biologics that are designed for delivery via the subcutaneous route, based on several relevant parameters, such as ...

Subcutaneous Biologics, Technologies and Drug Delivery Systems 2020-2030 - ResearchAndMarkets.com June 23, 2020 06:24 AM Eastern Daylight Time ...